|
| |
| | | 55937 | | 25.06.2002 | | Viatris Pharma GmbH | | 06.06.2007 | | | | | | | | | | | 06.03.30. | | | | 06.03. | | IPro |
| | Seq.-nr. | Préparation | Description | Forme galénique | Classe d'ATC | |
|---|
| 01 | Arixtra 2.5 mg/0.5 ml | Injektionslösung | Solution injectable (Fondaparinuxum Natricum 2.5mg / 0.5ml) | B01AX05 | IPat | | 02 | Arixtra 1.5 mg/0.3 ml | Injektionslösung | Solution injectable (Fondaparinuxum Natricum 1.5mg / 0.3ml) | B01AX05 | IPat | | 03 | Arixtra 5.0 mg/0.4 ml | Injektionslösung | Solution injectable (Fondaparinuxum Natricum 5mg / 0.4ml) | B01AX05 | IPat | | 04 | Arixtra 7.5 mg/0.6 ml | Injektionslösung | Solution injectable (Fondaparinuxum Natricum 7.5mg / 0.6ml) | B01AX05 | IPat | | 05 | Arixtra 10 mg/0.8 ml | Injektionslösung | Solution injectable (Fondaparinuxum Natricum 10mg / 0.8ml) | B01AX05 | IPat |
|
|
|
